These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35280814)

  • 1. A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.
    Hu J; Lai C; Shen Z; Yu H; Lin J; Xie W; Su H; Kong J; Han J
    Front Oncol; 2022; 12():833763. PubMed ID: 35280814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
    Front Oncol; 2023; 13():972558. PubMed ID: 37064115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
    Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
    Front Immunol; 2022; 13():916800. PubMed ID: 35860239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
    Li X; Chen J; Yu Q; Huang H; Liu Z; Wang C; He Y; Zhang X; Li W; Li C; Zhao J; Long W
    Front Genet; 2021; 12():569318. PubMed ID: 33796128
    [No Abstract]   [Full Text] [Related]  

  • 5. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
    Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K
    Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Long Non-coding RNAs Associated With Microenvironment on Survival for Bladder Cancer Patients.
    Lin G; Guo B; Wei Y; Lan T; Wen S; Li G
    Front Genet; 2020; 11():567200. PubMed ID: 33281872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer.
    Luo J; Peng J; Xiao W; Huang S; Cao Y; Wang T; Wang X
    Front Genet; 2022; 13():984696. PubMed ID: 36092933
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer.
    Zheng Z; Lai C; Li W; Zhang C; Ma K; Yao Y
    Front Genet; 2021; 12():720421. PubMed ID: 34490046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
    Yang FL; Hong K; Zhao GJ; Liu C; Song YM; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):615-622. PubMed ID: 31420610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
    Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
    Front Oncol; 2021; 11():640150. PubMed ID: 33869028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of 11 metabolic-related lncRNAs to predict the prognosis in lung adenocarcinoma.
    Jiang W; Xu Z; Huang L; Qin F; Yuan L; Sun Y; Qin J; Deng K; Zheng T; Long X; Li S
    BMC Med Genomics; 2023 Dec; 16(1):330. PubMed ID: 38110999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of four-metabolism related-long non-coding RNAs as potential signature in prognosis of colon cancer.
    Chen G; Dong Y; Shi W; Li L; Zhu W; Xie L; Song X
    Transl Cancer Res; 2022 Apr; 11(4):725-735. PubMed ID: 35571667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a prognostic model of colon cancer patients based on metabolism-related lncRNAs.
    Li C; Liu Q; Song Y; Wang W; Zhang X
    Front Oncol; 2022; 12():944476. PubMed ID: 36248984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.
    Li P; Li J; Wen F; Cao Y; Luo Z; Zuo J; Wu F; Li Z; Li W; Wang F
    Front Oncol; 2022; 12():966920. PubMed ID: 36276132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients.
    Peng J; Hao Y; Rao B; Zhang Z
    Transl Cancer Res; 2021 Nov; 10(11):4802-4816. PubMed ID: 35116333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the endoplasmic reticulum stress-related long non-coding RNA in bladder cancer.
    Wu Z; Wang Y; Yan M; Liang Q; Li B; Hou G; Xia T; Lin Z; Xu W
    Front Oncol; 2022; 12():951631. PubMed ID: 35992824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of a Long Non-coding RNA associated Signature to Predict Survival in Patients with Bladder Cancer.
    Zhong W; Qu H; Yao B; Wang D; Qiu J
    Cureus; 2022 May; 14(5):e24818. PubMed ID: 35693359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.
    Huang ZL; Li W; Chen QF; Wu PH; Shen LJ
    World J Gastrointest Oncol; 2019 Nov; 11(11):983-997. PubMed ID: 31798779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
    Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
    Front Oncol; 2020; 10():780. PubMed ID: 32587825
    [No Abstract]   [Full Text] [Related]  

  • 20. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.